Found 6 matching trials
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
PHASE2Tthe primary objective of this study is to compare blinded Independent Radi...
Location
University of Alabama at Birmingham
Study to Evaluate the ECG Effects of Telaglenastat in Healthy Adult Subjects
PHASE1This study is designed to evaluate the effects of telaglenastat on cardiac ...
Impact of a Histamine H2 Receptor Antagonist (H2RA) on the Pharmacokinetics (PK) of Telaglenastat in Healthy Subjects
PHASE1This study is designed to formally evaluate the impact of famotidine, an H2...
Location
Nucleus Network Brisbane Clinic (formerly Q-Pharm)
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC
PHASE2This is a Phase 2, randomized, multicenter, double-blind study of the gluta...
Location
University of Alabama at Birmingham
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)
PHASE2The primary objective of this study is to compare the progression-free surv...
Location
The University of Arizona Cancer Center
NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial
N/AThis is a multicenter screening protocol designed to identify patients with...
Location
Southern Cancer Center